Isoimperatorin Inhibits Angiogenesis by Suppressing VEGFR2 Signaling Pathway.
Yating XuDi XiaShan DengMinglu LiangPublished in: Cardiovascular drugs and therapy (2024)
Our study showed that isoimperatorin suppressed angiogenesis by targeting the VEGFR2 signaling pathway and could be a potential therapeutic agent for targeting angiogenesis.